Literature DB >> 17900983

Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Tonyia Eaves-Pyles1, Christopher A Allen, Joanna Taormina, Alexander Swidsinski, Christopher B Tutt, G Eric Jezek, Martha Islas-Islas, Alfredo G Torres.   

Abstract

Inflammatory diseases of the intestinal tract are a major health concern both in the United States and around the world. Evidence now suggests that a new category of Escherichia coli, designated Adherent Invasive E. coli (AIEC) is highly prevalent in Crohn's Disease (CD) patients. AIEC strains have been shown to colonize and adhere to intestinal epithelial cells (IEC). However, the role AIEC strains play in the induction of an inflammatory response is not known. Therefore, we examined several E. coli strains (designated LF82, O83:H1, 6604 and 6655) that were isolated from CD patients for their ability to induce inflammation in two IEC, Caco-2BBe and T-84 cells. Results showed that each strain had varying abilities to adhere to and invade IEC as well as induced cytokine secretion from polarized IEC. However, E. coli O83:H1 displayed the best characteristics of AIEC strains as compared to the prototype AIEC strain LF82, inducing cytokine secretion from IEC and promoting immune cell migration through IEC. Upon further analysis, E. coli O83:H1 did not harbor virulence genes present in known pathogenic intestinal organisms. Further characterization of E. coli O83:H1 virulence determinants showed that a non-flagellated O83:H1 strain significantly decreased the organism's ability to adhere to and invade both IEC and elicit IEC cytokine secretion compared to the wild type and complemented strains. These findings demonstrate that E. coli O83:H1 possesses the characteristics of the AIEC LF82 strain that may contribute to the low-grade, chronic inflammation observed in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900983     DOI: 10.1016/j.ijmm.2007.05.011

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  74 in total

Review 1.  Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation.

Authors:  H T Tran; N Barnich; E Mizoguchi
Journal:  Histol Histopathol       Date:  2011-11       Impact factor: 2.303

Review 2.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 3.  Crohn disease: a current perspective on genetics, autophagy and immunity.

Authors:  Thaddeus S Stappenbeck; John D Rioux; Atsushi Mizoguchi; Tatsuya Saitoh; Alan Huett; Arlette Darfeuille-Michaud; Tom Wileman; Noboru Mizushima; Simon Carding; Shizuo Akira; Miles Parkes; Ramnik J Xavier
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

4.  Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation.

Authors:  Benoit Chassaing; Estelle Garénaux; Jessica Carriere; Nathalie Rolhion; Yann Guérardel; Nicolas Barnich; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  J Bacteriol       Date:  2015-02-09       Impact factor: 3.490

Review 5.  Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature.

Authors:  Györgyi Műzes; Zsolt Tulassay; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

6.  The flagella of an atypical enteropathogenic Escherichia coli strain are required for efficient interaction with and stimulation of interleukin-8 production by enterocytes in vitro.

Authors:  Suely C F Sampaio; Tânia A T Gomes; Christophe Pichon; Laurence du Merle; Stéphanie Guadagnini; Cecilia M Abe; Jorge L M Sampaio; Chantal Le Bouguénec
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

7.  Adherent-invasive Escherichia coli target the epithelial barrier.

Authors:  Eytan Wine; Juan C Ossa; Scott D Gray-Owen; Philip M Sherman
Journal:  Gut Microbes       Date:  2010-01-05

8.  Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.

Authors:  A Jarry; L Crémet; N Caroff; C Bou-Hanna; J M Mussini; A Reynaud; A L Servin; J F Mosnier; V Liévin-Le Moal; C L Laboisse
Journal:  Mucosal Immunol       Date:  2014-10-01       Impact factor: 7.313

9.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

10.  Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Authors:  Frédéric A Carvalho; Nicolas Barnich; Adeline Sivignon; Claude Darcha; Carlos H F Chan; Clifford P Stanners; Arlette Darfeuille-Michaud
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.